Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Penny A Dacks"'
Autor:
Cesar L Moreno, Linda Yang, Penny A Dacks, Fumiko Isoda, Jan M A van Deursen, Charles V Mobbs
Publikováno v:
PLoS ONE, Vol 11, Iss 11, p e0166381 (2016)
We have reported a correlation between hypothalamic expression of Creb-binding protein (Cbp) and lifespan, and that inhibition of Cbp prevents protective effects of dietary restriction during aging, suggesting that hypothalamic Cbp plays a role in re
Externí odkaz:
https://doaj.org/article/5860959c15674cc582f033695ca9b5e1
Autor:
Rita Sattler, Bryan J. Traynor, Janice Robertson, Ludo Van Den Bosch, Sami J. Barmada, Clive N. Svendsen, Matthew D. Disney, Tania F. Gendron, Philip C. Wong, Martin R. Turner, Adam Boxer, Suma Babu, Michael Benatar, Michael Kurnellas, Jonathan D. Rohrer, Christopher J. Donnelly, Lynette M. Bustos, Kendall Van Keuren-Jensen, Penny A. Dacks, Marwan N. Sabbagh, Attendees of the inaugural C9ORF72 FTD/ALS Summit
Publikováno v:
Neurology and Therapy, Vol 12, Iss 6, Pp 1821-1843 (2023)
Abstract A summit held March 2023 in Scottsdale, Arizona (USA) focused on the intronic hexanucleotide expansion in the C9ORF72 gene and its relevance in frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS; C9ORF72-FTD/ALS). The goal
Externí odkaz:
https://doaj.org/article/29cedee3ed35403a952639263a5b1ede
Living With Frontotemporal Degeneration: Diagnostic Journey, Symptom Experiences, and Disease Impact
Autor:
Megan S. Barker, Shana G. Dodge, Debra Niehoff, Sharon Denny, Penny A. Dacks, Susan Dickinson, Stephanie Cosentino, Dianna K.H. Wheaton
Publikováno v:
Journal of Geriatric Psychiatry and Neurology. 36:201-214
Frontotemporal degeneration (FTD) is an umbrella term encompassing a range of rare neurodegenerative disorders that cause progressive declines in cognition, behavior, and personality. Hearing directly from individuals living with FTD and their care p
Publikováno v:
Alzheimer's & Dementia. 18
Autor:
Megan S Barker, Jillian L. Joyce, Shana G. Dodge, Debra Niehoff, Sharon S. Denny, Penny A. Dacks, Susan Dickinson, Stephanie Cosentino, Dianna K.H. Wheaton
Publikováno v:
Alzheimer's & Dementia. 18
Autor:
Emily A, Largent, Sarah, Walter, Nancy, Childs, Penny A, Dacks, Shana, Dodge, Hana, Florian, Jonathan, Jackson, Jorge J, Llibre Guerra, Erin, Iturriaga, David S, Miller, Monica, Moreno, Rachel L, Nosheny, Thomas O, Obisesan, Elena, Portacolone, Bernadette, Siddiqi, Nina, Silverberg, Rueben C, Warren, Kathleen A, Welsh-Bohmer, Rebecca M, Edelmayer
Publikováno v:
Alzheimer'sdementia : the journal of the Alzheimer's AssociationREFERENCES.
Between 2018 and 2019, multiple clinical trials ended earlier than planned, resulting in calls to improve communication with and support for participants and their study partners ("dyads"). The multidisciplinary Participant Follow-Up Improvement in R
Autor:
Debra Niehoff, Shana G Dodge, Elizabeth Graham, Megan S Barker, Stephanie Cosentino, Dianna KH Wheaton, Sharon S Denny, Penny A Dacks, Susan Dickinson
Publikováno v:
Alzheimer's & Dementia. 17
Autor:
Stephen F, Traynelis, Dennis, Dlugos, David, Henshall, Heather C, Mefford, Michael A, Rogawski, Kevin J, Staley, Penny A, Dacks, Vicky, Whittemore, Annapurna, Poduri
Publikováno v:
Epilepsy Currents
The goals of Epilepsy Benchmark Area III involve identifying areas that are ripe for progress in terms of controlling seizures and patient symptoms in light of the most recent advances in both basic and clinical research. These goals were developed w
Publikováno v:
Alzheimer's & Dementia : Translational Research & Clinical Interventions
Introduction Informed consent forms that restrict the distribution of data and samples have been an impediment to advancing Alzheimer's disease (AD) understandings and treatments. The Coalition Against Major Disease public-private partnership develop
Autor:
Diane Stephenson, Viswanath Devanarayan, Stuart Maudsley, Penny A. Dacks, Klaus Romero, Hugo Geerts, Zaven S. Khachaturian, Mark Forrest Gordon, Magali Haas
Publikováno v:
Alzheimer's & dementia
Massive investment and technological advances in the collection of extensive and longitudinal information on thousands of Alzheimer patients results in large amounts of data. These "big-data" databases can potentially advance CNS research and drug de